- ZEISS is expanding its STEM activities to all locations
- Global promotion of STEM by ZEISS employees
Oberkochen, Germany | 7 June 2022 | ZEISS Group
The new future-oriented initiative A Heart for Science, a corporate volunteering program, is just about to get underway. To mark its 175th anniversary, ZEISS launched its global initiative A Heart for Science that is intended to encourage young people to pursue a career in STEM.
The special thing about the initiative is that it's being planned and organized by ZEISS employees. From today, employees across the world are taking part in a corporate volunteering program and are passing on their knowledge to the explorers of tomorrow.
ZEISS is supporting the commitment of its employees to this in many ways including a handbook about the initiative, age-appropriate guided experiments, and a digital platform where volunteers can get together and collaborate on their joint projects. Selected activities are also being funded by ZEISS.
"Supporting education and science is a tradition at ZEISS. It is a core part of our philosophy. The aim of A Heart for Science is to open up the world of research up to young people and to get them excited about nature and technology", said Dr. Karl Lamprecht, President and CEO of the ZEISS Group.
By introducing this initiative, ZEISS intends to grow an international network of internal and external project partners.
Employees can work with educational institutions and learning venues such as schools, student labs or museums by teaching, carrying out experiments or organizing STEM workshops. In this way, Zeissians can bring their experience and expertise to bear and benefit their local communities.
Further information and contact details are available at: zeiss.com/aheartforscience
ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling 7.5 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets (status: 30 September 2021).
For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.
With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company's significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS' technology and market leadership. ZEISS invests 13 percent of its revenue in research and development – this high level of expenditure has a long tradition at ZEISS and is also an investment in the future.
With around 37,000 employees, ZEISS is active globally in almost 50 countries with around 30 production sites, 60 sales and service companies and 27 research and development facilities (status: 31 March 2022). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.
Further information at www.zeiss.com